“We’re at a critical moment for precision medicine in cancer care”
Cancer will only be beaten when the genomic drivers of a person’s cancer are understood and targeted, according to Brian Tomlinson of Foundation Medicine Tell me about yourself and your organization Foundation Medicine is a molecular information company dedicated to transforming cancer care through a deep understanding of the genomic changes that contribute to each […]
‘We need truly collaborative initiatives like this’
Begonya Nafria Escalera of Sant Joan de Déu Children’s Hospital in Barcelona has both a professional and personal interest in ensuring that patients’ needs are met by personalized medicine Tell me about yourself and your organization I’m working at Sant Joan de Déu Children’s Hospital as Patient Engagement in Research Coordinator. My area of responsibility […]
‘We have a growing scientific understanding of how unique diseases are, at an individual level’
Making personalized healthcare an accessible reality for as many people as possible has been a priority for Sandra Blum of Roche’s Global Patient Partnership team for many years Tell us more about yourself and your organization. I am part of the Global Patient Partnership team at Roche. ‘Partnership’ is not just part of our name. […]
‘I am on a mission to fix that’
Susan McClure, founder and CEO of Genome Creative, says that while clinical adoption of targeted treatments remains low, multi-stakeholder efforts such as FT3 can change this Tell us more about your organization We specialize in content strategy, editorial and design updates, event creation and management, websites, podcasts, apps, and marketing. Specifically, we work with partners […]
‘True personalized medicine should be the goal’
Dr Benedikt Westphalen is a medical oncologist and molecular biologist, focusing on gastrointestinal oncology and precision oncology. For the last four years, he has been building a precision oncology program at the University of Munich.
‘Personalized medicine is more than just medicine’
FT3 is unique in having patients as a fundamental and essential partner, says project member Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders Tell us more about yourself. I am President & CEO of the Canadian Organization for Rare Disorders (CORD). As head of a global alliance of rare disease patient […]
‘This is the next generation of healthcare’
Ralph Riley is a Global Co Dx Market Access Leader with Janssen. As an FT3 member, he believes that the increased adoption of personalized medicine will create value across the entire health ecosystem Tell us more about yourself. I am the Global Co Dx Market Access Leader where I focus on evidence generation activities to […]
‘Personalized medicine transcends the disease-specific approach’
FT3 member Ivica Belina, President of the Coalition of Associations in Healthcare, says a multistakeholder approach is essential in order to foster a culture of personalized medicine in healthcare Tell me about yourself? I’m the president of Coalition of Association in Healthcare, a national umbrella patient organization in Croatia, which gathers over 30 patient organizations […]
‘This is a unique collaboration’
Tanya Knott, Director, SJK Foundation, spoke to Danielle Barron about her vision of personalized medicine and the personal tragedy that drives her to make it a reality. Tell us more about you I am the founder and director of the Sarah Jennifer Knott Foundation. I established the foundation with family and friends in 2016 following […]
‘No two people are the same’
President of Lung Cancer Europe and molecular biologist, Dr. Anne-Marie Baird says personalized medicine should mean the best medicine, care, and support for people on an individualized basis Tell us more about yourself? I am a molecular biologist and have worked extensively on mesothelioma and lung cancer, with research interests in inflammation, the metastatic cascade, […]